Skip to main content
SpringerLink
Log in

Nachsorge zur Rezidivprophylaxe bei Tumoren des Peritoneums

  • Chapter
Peritoneale Tumoren und Metastasen

  • 1621 Accesses

Zusammenfassung

Unabhängig von der Tumorentität stellt die Diagnose der Peritonealkarzinose im frühen Stadium den wesentlichen Prognosefaktor dar. Hierin liegt die besondere Bedeutung der Nachsorge, die adaptiert an das individuelle Risiko und mit der höchstmöglichen Sensitivität durchgeführt werden sollte. Es werden für die primären und sekundären Peritonealkarzinosen die für die Nachsorge relevanten Daten dargestellt und die daraus ableitbaren Empfehlungen formuliert.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Baratti, D et al. (2007) Circulating CA125 in patients with peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 14: 500–508. www.ncbi.nlm.nih.gov/pubmed/17151789

    Article  Google Scholar 

  • Baratti, D, et al. (2012) Cytoreductive Surgery with Selective Versus Complete Parietal Peritonectomy Followed by Hyperthermic Intraperitoneal Chemotherapy in Patients with Diffuse Malignant Peritoneal Mesothelioma: A Controlled Study. Ann Surg Oncol 19: 1416–1424

    Article  Google Scholar 

  • Berthelot C, et al. (2011) Use of FDG-PET/CT for peritoneal carcinomatosis before hyperthermic intraperitoneal chemotherapy. Nucl Med Commun 32: 23–29. www.ncbi.nlm.nih.gov/pubmed/21042225

  • Bijelic L, Yan TD, Sugarbaker PH (2008) Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms. J Surg Oncol 98: 295–299

    Article  Google Scholar 

  • Brodsky JT, Cohen M (1991) Peritoneal seeding following potentially curative resection of colonic carcinoma: implications for adjuvant therapy. Dis Colon Rectum 34: 723–727. www.ncbi.nlm.nih.gov/pubmed/1855433

    Article  CAS  Google Scholar 

  • Carmignani CP, et al. (2004) Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix. J Surg Oncol, 87: 162–166

    Google Scholar 

  • Chia CS, et al. (2016) Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility? Ann Surg Oncol, 1971–1979.

    Google Scholar 

  • Coccolini, F, et al. (2016) Hyperthermic intraperitoneal chemotherapy (HIPEC) and neoadjuvant chemotherapy as prophylaxis of peritoneal carcinosis from advanced gastric cancer—effects on overall and disease free survival. J Gastrointest Cancer 7: 523–529. http: //jgo.amegroups.com/article/view/8277/7599

    Article  Google Scholar 

  • Denzer U, et al. (2004) Minilaparoscopy in the diagnosis of peritoneal tumor spread: prospective controlled comparison with computed tomography. Surg Endosc 18: 1067–1070. www.ncbi.nlm.nih.gov/pubmed/15156385

  • Deraco M, et al. (2008) Consensus statement on peritoneal mesothelioma. J Surg Oncol 98: 268–272

    Article  Google Scholar 

  • Elias D, et al. (2008) Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 247: 445–450

    Article  Google Scholar 

  • Elias D, et al. (2011) Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 254: 289–293

    Article  CAS  Google Scholar 

  • Glehen O, et al. (2004) Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis from Colorectal Cancer: A Multi-Institutional Study. J Clin Oncol 22: 3284–3292

    Article  CAS  Google Scholar 

  • Honoré C, et al. (2012) Definition of Patients Presenting a High Risk of Developing Peritoneal Carcinomatosis After Curative Surgery for Colorectal Cancer: A Systematic Review. Ann Surg Oncol 20: 183–192

    Article  Google Scholar 

  • Kusamura S, et al. (2013) Circulating tumor markers: Predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritonei. J Surg Oncol 108: 1–8

    Article  CAS  Google Scholar 

  • McDonald JR, et al. (2012) Classification of and cytoreductive surgery for low-grade appendiceal mucinous neoplasms. Br J Surg 99: 987–992

    Article  CAS  Google Scholar 

  • Moran B, et al. (2008) Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol 98: 277–282

    Article  Google Scholar 

  • Nozoe T, et al. (2000) Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol 75: 103–107. www.ncbi.nlm.nih.gov/pubmed/11064389

    Article  CAS  Google Scholar 

  • Park MJ, et al. (2009) Detecting recurrence of gastric cancer: The value of FDG PET/CT. Abdom Imaging 34: 441–447

    Article  Google Scholar 

  • Quere P, et al. (2015) Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study. Dis Colon Rectum 58: 743–752. www.ncbi.nlm.nih.gov/pubmed/26163953

    Article  CAS  Google Scholar 

  • Roviello F, et al. (2003) Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 90: 1113–1119

    Article  CAS  Google Scholar 

  • Sardi A, et al. (2013) Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: Analysis of survival outcomes. Eur J Surg Oncol 39: 1207–1213. Doi: dx.doi.org/10.1016/j.ejso.2013.08.017

  • Setoyama T, et al. (2007) a-Catenin is a significant prognostic factor than E-cadherin in esophogeal squamous cell carcinoma. J Surg Oncol 95: 148–155

    Article  CAS  Google Scholar 

  • Slanetz CA (1984) The effect of inadvertent intraoperative perforation on survival and recurrence in colorectal cancer. Dis Colon Rectum 27: 792–797

    Article  Google Scholar 

  • Smeenk RM, et al. (2008) Appendiceal neoplasms and pseudomyxoma peritonei: A population based study. Eur J Surg Oncol 34: 196–201

    Article  CAS  Google Scholar 

  • Sun J, et al. (2012) Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials. BMC cancer 12: 526. www.biomed central.com/1471–2407/12/526

  • Valle M, Garofalo A (2006) Laparoscopic staging of peritoneal surface malignancies. Eur J Surg Oncol 32: 625–627

    Article  Google Scholar 

  • Verwaal VJ, et al. (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21: 3737–3743

    Article  Google Scholar 

  • Willett C, et al. (1985) Obstructive and perforative colonic carcinoma: Patterns of failure. J Clin Oncol 3: 379–384

    Article  CAS  Google Scholar 

  • Yan TD, et al. (2016) Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience. J Clin Oncol 27: 6237-6242

    Article  Google Scholar 

  • Yan TD, Bijelic L, Sugarbaker PH (2007) Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Ann Surg Oncol 14: 2289–2299

    Article  Google Scholar 

  • Yang SH, et al. (2004) Risk factors for peritoneal dissemination of colorectal cancer. J Surg Oncol 87: 167–173. www.ncbi.nlm.nih.gov/pubmed/15334631

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinikum Giessen und Marburg, ­Standort Gießen, Klinik für Allgemein-, Viszeral-, Thorax-, ­Transplantations- und Kinderchirurgie, Rudolf-Buchheim-Straße 7, 35392, Gießen, Deutschland

    PD Dr. med. R. Hörbelt

  2. Universitätsklinikum Gießen und Marburg, ­Standort Gießen, Klinik für Allgemein-, Viszeral-, Thorax-, ­Transplantations- und Kinderchirurgie, Rudolf-Buchheim-Straße 7, 35392, Gießen, Deutschland

    Prof. Dr. med. W. Padberg

Authors
  1. PD Dr. med. R. Hörbelt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. W. Padberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to R. Hörbelt or W. Padberg .

Editor information

Editors and Affiliations

  1. Charité Campus Virchow-Klinikum, Berlin, Deutschland

    Beate Rau

  2. Krankenhaus Barmherzige Brüder, Regensburg, Deutschland

    Pompiliu Piso

  3. Universitätsklinikum Tübingen, Tübingen, Deutschland

    Alfred Königsrainer

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag GmbH Deutschland

About this chapter

Cite this chapter

Hörbelt, R., Padberg, W. (2018). Nachsorge zur Rezidivprophylaxe bei Tumoren des Peritoneums. In: Rau, B., Piso, P., Königsrainer, A. (eds) Peritoneale Tumoren und Metastasen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54500-3_38

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-54500-3_38

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-54499-0

  • Online ISBN: 978-3-662-54500-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation